Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan-Mar;45(1):8-16.
doi: 10.1590/2175-8239-JBN-2021-0242en.

Comparative analysis of patients' survival on hemodialysis vs. peritoneal dialysis and identification of factors associated with death

[Article in English, Portuguese]
Affiliations

Comparative analysis of patients' survival on hemodialysis vs. peritoneal dialysis and identification of factors associated with death

[Article in English, Portuguese]
Carolina Aparecida de Almeida Vicentini et al. J Bras Nefrol. 2023 Jan-Mar.

Abstract

Introduction: There are several studies comparing the outcomes of patients treated with peritoneal dialysis (PD) and hemodialysis (HD), and most are divergent.

Methods: This is a cohort study that followed patients with incident PD and HD in a planned and unplanned way, in a dialysis unit of the HCFMB from 01/2014 to 01/2019, until the outcome. We collected clinical and laboratory data. The PD and HD groups, death and non-death outcomes, were compared using the chi-square test for categorical variables and t-test, or Mann-Whitney test for continuous variables. Kaplan Meier curve and log-rank test were used for survival. Multivariate analysis was performed using the Cox regression. The significant difference was p < 0.05.

Results: We had 592 patients, 290 treated by HD and 302 by PD. The mean age was 59.9 ± 16.8, with a predominance of males (56.3%), the main underlying disease was diabetes (45%); 29% of the patients died. There was no difference in the survival of patients treated by HD and PD. The oldest age (1.018 (95% CI 1.000-1.037; p=0.046)) was identified as a risk factor for death, while the highest number of infection-free days (0.999 (95% CI 0.999-1.000; p=0.003 )) as a protective factor.

Conclusion: The analysis reinforced that the survival of patients on HD and PD was similar. Higher age and shorter infection-free time were associated with death.

Introdução:: Há vários estudos que comparam os desfechos de pacientes tratados por diálise peritoneal (DP) e hemodiálise (HD), e a maioria é divergente.

Métodos:: Estudo de coorte que acompanhou pacientes incidentes em DP e HD de modo planejado e não planejado em unidade de diálise do HCFMB de 01/2014 a 01/2019, até o desfecho. Foram coletados dados clínicos e laboratoriais. Comparou-se os grupos DP e HD, óbito e não óbito, por meio do teste qui-quadrado para variáveis categóricas e teste t ou Mann-Whitney para as contínuas. Curva de Kaplan Meier e log-rank test foram utilizados para a sobrevida. A análise multivariada foi realizada por Regressão de Cox. A diferença significante foi de p < 0,05.

Resultados:: Foram estudados 592 pacientes, 290 tratados por HD e 302 por DP. A média de idade foi de 59,9 ± 16,8, com predomínio de sexo masculino (56,3%), principal doença de base, diabetes (45%). Óbito ocorreu em 29% dos pacientes. Não houve diferença na sobrevida de pacientes tratados por HD e DP. A maior idade (1,018 (IC 95% 1,000-1,037; p=0,046)) foi identificada como fator de risco para o óbito, enquanto a maior quantidade de dias livres de infecção (0,999 (IC 95% 0,999-1,000; p=0,003)), como fator de proteção.

Conclusão:: A análise reforçou que a sobrevida dos pacientes em HD e DP é semelhante. Foram associados ao óbito a maior idade e o menor tempo livre de infecção.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: There is no conflict of interest in this study.

Figures

Figure 1
Figure 1. Survival and infection-free time analysis of patients in HD and PD.

Comment in

  • Peritoneal dialysis: why not?
    Andreoli MCC, Totoli C, Rocha DRD, Campagnaro LS. Andreoli MCC, et al. J Bras Nefrol. 2023 Jan-Mar;45(1):1-2. doi: 10.1590/2175-8239-JBN-2023-E001en. J Bras Nefrol. 2023. PMID: 37015051 Free PMC article. No abstract available.

References

    1. Penico MG, Paulo Koah. Cartilha dia Mundial do Rim. S. l: Sociedade Brasileira de Nefrologia; mar. 2016. [Acesso em: 22 set. 2019]. Disponível em: https://arquivos.sbn.org.br/uploads/dmr2016_cartilha.pdf .
    1. Censo da Sociedade Brasileira de Nefrologia. 2017. [Acesso em: 04, Junho, 2019]. Disponível em < www.sbn.org.br>.
    1. Beraldo N. Saúde alerta para prevenção e diagnóstico precoce da Doença Renal Crônica. S. l: Ministério da Saúde; mar. 2019. [Acesso em: 22 set 2019]. Disponível em: http://www.saude.gov.br/noticias/agencia-saude/45291-ministerio-da-saude... .
    1. Niang A; A, Iyengar A, Luychx V. Current Opinion in Nephrology and Hypertension. S. l: nov. 2018. Hemodialysis versus peritoneal dialysis in resource-limited setting; pp. 463–471. Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/30148722 . - PubMed
    1. Thiery A, Séverac F, Hannedouche T, Couchoud C, Do VH, Tiple A, et al. Survival advantage of planned haemodialysis over peritoneal dialysis: A cohort study. Nephrol Dial Transplant. 2018 - PubMed